Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)

NCT01953640 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01953640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01953640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
May 30, 2013
Completion date
April 3, 2023
Enrollment
92 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hormone-resistant prostate cancer, metastatic prostate carcinoma, prostate adenocarcinoma, recurrent prostate carcinoma